Production (Stage)
Elanco Animal Health Incorporated
ELAN
$13.81
-$0.36-2.54%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.42% | 0.50% | 1.99% | 3.86% | -1.76% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.42% | 0.50% | 1.99% | 3.86% | -1.76% |
| Cost of Revenue | 2.31% | 3.73% | 8.32% | 8.93% | 2.85% |
| Gross Profit | 0.70% | -2.01% | -2.72% | 0.08% | -5.19% |
| SG&A Expenses | 1.71% | 2.19% | 0.93% | 1.33% | 2.06% |
| Depreciation & Amortization | -4.57% | -3.83% | -0.93% | 2.65% | 4.19% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.46% | 2.35% | 4.38% | 5.47% | 2.84% |
| Operating Income | 0.82% | -22.36% | -25.65% | -14.08% | -44.14% |
| Income Before Tax | 141.52% | 140.84% | 135.61% | -1,096.15% | -3,210.26% |
| Income Tax Expenses | 1,381.82% | 316.67% | 1,692.31% | 22.22% | 184.62% |
| Earnings from Continuing Operations | 128.65% | 127.46% | 117.92% | -1,010.62% | -4,907.69% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 128.65% | 127.46% | 117.92% | -1,010.62% | -4,907.69% |
| EBIT | 0.82% | -22.36% | -25.65% | -14.08% | -44.14% |
| EBITDA | -1.60% | -9.47% | -10.28% | -5.33% | -16.49% |
| EPS Basic | 128.54% | 127.38% | 117.83% | -1,003.51% | -4,757.72% |
| Normalized Basic EPS | 110.05% | -192.00% | -265.95% | -127.39% | -161.32% |
| EPS Diluted | 127.84% | 126.71% | 117.12% | -992.90% | -4,780.70% |
| Normalized Diluted EPS | 109.84% | -222.22% | -269.85% | -128.49% | -161.77% |
| Average Basic Shares Outstanding | 0.34% | 0.35% | 0.49% | 0.63% | 0.76% |
| Average Diluted Shares Outstanding | 0.57% | 0.58% | 0.72% | 0.68% | 0.82% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |